ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Association of O6-Methylguanine-DNA Methyltransferase Protein Expression With Postoperative Prognosis and Adjuvant Chemotherapeutic Benefits Among Patients With Stage II or III Gastric Cancer.

Cao Yifan; Liu Hao; Li He; Lin Chao; Li Ruochen; Wu Songyang; Zhang Heng; He Hongyong; Zhang Weijuan; Xu Jiejie
JAMA Surgery2017-9-13DOI: 10.1001/jamasurg.2017.3120
6阅读
引用收藏
分享

摘要

Importance: Loss of O6-methylguanine-DNA methyltransferase (MGMT) protein expression has been reported in several malignant tumors and predicts dismal survival outcomes. In gastric cancer, existing studies on this topic are limited and the association between MGMT and fluorouracil-based adjuvant chemotherapy remains obscure. Objective: To investigate the postoperative prognostic significance of MGMT in patients with resectable gastric cancer and its responsiveness to fluorouracil-based adjuvant chemotherapy. Design, Setting, and Participants: This study recruited 445 consecutive patients with resectable gastric cancer who underwent radical gastrectomy between August 1, 2007, and December 30, 2008, at Zhongshan Hospital at Fudan University in Shanghai, China. Patients were randomly divided into a discovery data set (n = 200) and a validation data set (n = 245), and the range of follow-up time was from 2 to 76 months for the discovery group and 2 to 79 months for the validation group. The immunoreactivity for MGMT in cancer cells was reviewed under a light microscope by 2 pathologists who were blinded to the clinicopathological data. The association of MGMT expression with clinicopathological characteristics and measures and prognosis was inspected. Data and specimens were collected from patients from the date of surgery to April 25, 2014. Data analysis took place from May 9, 2016, to July 15, 2016. Main Outcomes and Measures: Estimates of overall survival on the basis of MGMT expression and hazard ratio (HR) for estimates of overall mortality risk. Results: Of the 445 patients included in the study, 315 (70.8%) were men, and the mean (SD) age of all patients was 60 (12) years. Positive expression of MGMT indicated better overall survival for patients with stage II or III gastric cancer in both the discovery data set (HR, 0.52; 95% CI, 0.32-0.84; P = .003) and the validation data set (HR, 0.63; 95% CI, 0.43-0.93; P = .01). Multivariate analysis identified MGMT expression and TNM stage as 2 independent prognostic factors for overall survival. In stage II disease, the benefit from fluorouracil-based adjuvant chemotherapy was superior among MGMT-positive patients (HR, 0.35; 95% CI, 0.13-0.95; P = .007 for interaction) compared with MGMT-negative patients. Conclusions and Relevance: Positive expression of MGMT in gastric cancer was identified as an independent, favorable prognostic factor. Incorporating MGMT expression into the current TNM staging system could lead to better prognostic accuracy. These findings should be confirmed within the framework of randomized clinical trials associated with genomic DNA sequencing studies.

相关
加载中…
  • Prognostic value of excision repair cross-complementation group 1 expression in gastric cancer: A meta-analysis
    Song Peng; Yin Qin; Lu Ming; Fu Bo; Wang Baolin; Zhao QinghongExperimental and Therapeutic Medicine, 2015, 9(4): 1393-1400.
  • Adjuvant chemotherapy, p53, carcinoembryonic antigen expression and prognosis after D2 gastrectomy for gastric adenocarcinoma
    He Ming Ming; Zhang Dong Sheng; Wang Feng; Wang Zhi Qiang; Luo Hui Yan; Ren Chao; Jin Ying; Chen Dong Liang; Xu Rui Hua*World Journal of Gastroenterology, 2014, 20(1): 264-273.被引 1
  • Association of Tumor-Associated Collagen Signature With Prognosis and Adjuvant Chemotherapy Benefits in Patients With Gastric Cancer
    Chen, Dexin; Chen, Hao; Chi, Liangjie; Fu, Meiting; Wang, Guangxing; Wu, Zhida; Xu, Shuoyu; Sun, Caihong; Xu, Xueqin; Lin, Liyan; Cheng, Jiaxin; Jiang, Wei; Dong, Xiaoyu; Lu, Jianping; Zheng, Jixiang; Chen, Gang; Li, Guoxin; Zhuo, Shuangmu*; Yan, Jun*JAMA Network Open, 2021, 4(11): e2136388.被引 10
查看全部 →

发表信息

论文状态
公开发表
期刊
JAMA Surgery
发表日期
2017-09-13
DOI
10.1001/jamasurg.2017.3120
语言
ENGLISH
期刊等级
Q1
成果收录
PUBMED

作者

  • C

    Cao Yifan (第一作者)

  • L

    Liu Hao

查看全部 10 位作者收起作者
  • L

    Li He

  • L

    Lin Chao

  • L

    Li Ruochen

  • W

    Wu Songyang

  • Z

    Zhang Heng

  • H

    He Hongyong

  • Z

    Zhang Weijuan

  • X

    Xu Jiejie

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417